Brain Aneurysm Treatment Market 2027 By Type, Condition, End User and Geography | The Insight Partners

Brain Aneurysm Treatment Market to 2027 - Global Analysis and Forecasts by Type (Surgery, Medication); Condition (Unruptured Aneurysm, Ruptured Aneurysm); End User (Hospitals, Clinics) and Geography

Report Code: TIPRE00004588 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Brain aneurysm refers to lumps which are found in blood vessels. It is also known as cerebral aneurysm or intracranial aneurysm. In some cases, brain aneurysm causes bleeding in the brain (i.e. hemorrhagic stroke). The brain aneurysm is most prevalent between age group of 35 to 60. It can be caused by the high blood pressure, atherosclerosis, and heredity, abnormal blood flow. The treatment for aneurysm is based on the type of aneurysm and its size.

MARKET DYNAMICS
The major factors driving the growth of the global brain aneurysm treatment market are increasing in number of blood pressure patients, advancement in surgical techniques, the family history such as heredity are some of the key factors driving the market growth of global brain aneurysm treatment market. The increasing research and development investment is expected to find new opportunities in brain aneurysm treatment market.

MARKET SCOPE
The "Global Brain Aneurysm Treatment Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global pharmaceutical market trend analysis. The report aims to provide an overview of brain aneurysm treatment market with detailed market segmentation by type, condition, end user and geography. The global brain aneurysm treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading brain aneurysm treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global brain aneurysm treatment market is segmented on the basis of type, condition and end users. Based on type, the market is segmented as surgery and medication. On the basis of condition, the global brain aneurysm treatment market is segmented into unruptured aneurysm, ruptured aneurysm. Based on end users, the market segmented into hospitals, clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global brain aneurysm treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The brain aneurysm treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting brain aneurysm treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the brain aneurysm treatment market in these regions.

MARKET PLAYERS
The reports cover key developments in the brain aneurysm treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from brain aneurysm treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for brain aneurysm treatment in the global market. Below mentioned is the list of few companies engaged in the brain aneurysm treatment market.

The report also includes the profiles of key brain aneurysm treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Medtronic plc.
  • Boston neurosciences
  • Raumedic AG
  • Integra life sciences
  • Sophysa ltd.
  • Microport scientific corporation
  • Orsan medical technologies
  • Spiegelberg GmbH
  • Johnson & Johnson services
  • Infrascan Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Brain Aneurysm Treatment Market - By Type
1.3.2 Brain Aneurysm Treatment Market - By Condition
1.3.3 Brain Aneurysm Treatment Market - By End User
1.3.4 Brain Aneurysm Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BRAIN ANEURYSM TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BRAIN ANEURYSM TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BRAIN ANEURYSM TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BRAIN ANEURYSM TREATMENT - GLOBAL MARKET OVERVIEW
6.2. BRAIN ANEURYSM TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BRAIN ANEURYSM TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SURGERY
7.3.1. Overview
7.3.2. Surgery Market Forecast and Analysis
7.4. MEDICATION
7.4.1. Overview
7.4.2. Medication Market Forecast and Analysis
8. BRAIN ANEURYSM TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - CONDITION
8.1. OVERVIEW
8.2. CONDITION MARKET FORECASTS AND ANALYSIS
8.3. UNRUPTURED ANEURYSM
8.3.1. Overview
8.3.2. Unruptured Aneurysm Market Forecast and Analysis
8.4. RUPTURED ANEURYSM
8.4.1. Overview
8.4.2. Ruptured Aneurysm Market Forecast and Analysis
9. BRAIN ANEURYSM TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
10. BRAIN ANEURYSM TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Brain Aneurysm Treatment Market Overview
10.1.2 North America Brain Aneurysm Treatment Market Forecasts and Analysis
10.1.3 North America Brain Aneurysm Treatment Market Forecasts and Analysis - By Type
10.1.4 North America Brain Aneurysm Treatment Market Forecasts and Analysis - By Condition
10.1.5 North America Brain Aneurysm Treatment Market Forecasts and Analysis - By End User
10.1.6 North America Brain Aneurysm Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Brain Aneurysm Treatment Market
10.1.6.1.1 United States Brain Aneurysm Treatment Market by Type
10.1.6.1.2 United States Brain Aneurysm Treatment Market by Condition
10.1.6.1.3 United States Brain Aneurysm Treatment Market by End User
10.1.6.2 Canada Brain Aneurysm Treatment Market
10.1.6.2.1 Canada Brain Aneurysm Treatment Market by Type
10.1.6.2.2 Canada Brain Aneurysm Treatment Market by Condition
10.1.6.2.3 Canada Brain Aneurysm Treatment Market by End User
10.1.6.3 Mexico Brain Aneurysm Treatment Market
10.1.6.3.1 Mexico Brain Aneurysm Treatment Market by Type
10.1.6.3.2 Mexico Brain Aneurysm Treatment Market by Condition
10.1.6.3.3 Mexico Brain Aneurysm Treatment Market by End User
10.2. EUROPE
10.2.1 Europe Brain Aneurysm Treatment Market Overview
10.2.2 Europe Brain Aneurysm Treatment Market Forecasts and Analysis
10.2.3 Europe Brain Aneurysm Treatment Market Forecasts and Analysis - By Type
10.2.4 Europe Brain Aneurysm Treatment Market Forecasts and Analysis - By Condition
10.2.5 Europe Brain Aneurysm Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe Brain Aneurysm Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Brain Aneurysm Treatment Market
10.2.6.1.1 Germany Brain Aneurysm Treatment Market by Type
10.2.6.1.2 Germany Brain Aneurysm Treatment Market by Condition
10.2.6.1.3 Germany Brain Aneurysm Treatment Market by End User
10.2.6.2 France Brain Aneurysm Treatment Market
10.2.6.2.1 France Brain Aneurysm Treatment Market by Type
10.2.6.2.2 France Brain Aneurysm Treatment Market by Condition
10.2.6.2.3 France Brain Aneurysm Treatment Market by End User
10.2.6.3 Italy Brain Aneurysm Treatment Market
10.2.6.3.1 Italy Brain Aneurysm Treatment Market by Type
10.2.6.3.2 Italy Brain Aneurysm Treatment Market by Condition
10.2.6.3.3 Italy Brain Aneurysm Treatment Market by End User
10.2.6.4 Spain Brain Aneurysm Treatment Market
10.2.6.4.1 Spain Brain Aneurysm Treatment Market by Type
10.2.6.4.2 Spain Brain Aneurysm Treatment Market by Condition
10.2.6.4.3 Spain Brain Aneurysm Treatment Market by End User
10.2.6.5 United Kingdom Brain Aneurysm Treatment Market
10.2.6.5.1 United Kingdom Brain Aneurysm Treatment Market by Type
10.2.6.5.2 United Kingdom Brain Aneurysm Treatment Market by Condition
10.2.6.5.3 United Kingdom Brain Aneurysm Treatment Market by End User
10.2.6.6 Rest of Europe Brain Aneurysm Treatment Market
10.2.6.6.1 Rest of Europe Brain Aneurysm Treatment Market by Type
10.2.6.6.2 Rest of Europe Brain Aneurysm Treatment Market by Condition
10.2.6.6.3 Rest of Europe Brain Aneurysm Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Brain Aneurysm Treatment Market Overview
10.3.2 Asia-Pacific Brain Aneurysm Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Brain Aneurysm Treatment Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Brain Aneurysm Treatment Market Forecasts and Analysis - By Condition
10.3.5 Asia-Pacific Brain Aneurysm Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Brain Aneurysm Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Brain Aneurysm Treatment Market
10.3.6.1.1 Australia Brain Aneurysm Treatment Market by Type
10.3.6.1.2 Australia Brain Aneurysm Treatment Market by Condition
10.3.6.1.3 Australia Brain Aneurysm Treatment Market by End User
10.3.6.2 China Brain Aneurysm Treatment Market
10.3.6.2.1 China Brain Aneurysm Treatment Market by Type
10.3.6.2.2 China Brain Aneurysm Treatment Market by Condition
10.3.6.2.3 China Brain Aneurysm Treatment Market by End User
10.3.6.3 India Brain Aneurysm Treatment Market
10.3.6.3.1 India Brain Aneurysm Treatment Market by Type
10.3.6.3.2 India Brain Aneurysm Treatment Market by Condition
10.3.6.3.3 India Brain Aneurysm Treatment Market by End User
10.3.6.4 Japan Brain Aneurysm Treatment Market
10.3.6.4.1 Japan Brain Aneurysm Treatment Market by Type
10.3.6.4.2 Japan Brain Aneurysm Treatment Market by Condition
10.3.6.4.3 Japan Brain Aneurysm Treatment Market by End User
10.3.6.5 South Korea Brain Aneurysm Treatment Market
10.3.6.5.1 South Korea Brain Aneurysm Treatment Market by Type
10.3.6.5.2 South Korea Brain Aneurysm Treatment Market by Condition
10.3.6.5.3 South Korea Brain Aneurysm Treatment Market by End User
10.3.6.6 Rest of Asia-Pacific Brain Aneurysm Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Brain Aneurysm Treatment Market by Type
10.3.6.6.2 Rest of Asia-Pacific Brain Aneurysm Treatment Market by Condition
10.3.6.6.3 Rest of Asia-Pacific Brain Aneurysm Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Brain Aneurysm Treatment Market Overview
10.4.2 Middle East and Africa Brain Aneurysm Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Brain Aneurysm Treatment Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Brain Aneurysm Treatment Market Forecasts and Analysis - By Condition
10.4.5 Middle East and Africa Brain Aneurysm Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Brain Aneurysm Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Brain Aneurysm Treatment Market
10.4.6.1.1 South Africa Brain Aneurysm Treatment Market by Type
10.4.6.1.2 South Africa Brain Aneurysm Treatment Market by Condition
10.4.6.1.3 South Africa Brain Aneurysm Treatment Market by End User
10.4.6.2 Saudi Arabia Brain Aneurysm Treatment Market
10.4.6.2.1 Saudi Arabia Brain Aneurysm Treatment Market by Type
10.4.6.2.2 Saudi Arabia Brain Aneurysm Treatment Market by Condition
10.4.6.2.3 Saudi Arabia Brain Aneurysm Treatment Market by End User
10.4.6.3 U.A.E Brain Aneurysm Treatment Market
10.4.6.3.1 U.A.E Brain Aneurysm Treatment Market by Type
10.4.6.3.2 U.A.E Brain Aneurysm Treatment Market by Condition
10.4.6.3.3 U.A.E Brain Aneurysm Treatment Market by End User
10.4.6.4 Rest of Middle East and Africa Brain Aneurysm Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Brain Aneurysm Treatment Market by Type
10.4.6.4.2 Rest of Middle East and Africa Brain Aneurysm Treatment Market by Condition
10.4.6.4.3 Rest of Middle East and Africa Brain Aneurysm Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Brain Aneurysm Treatment Market Overview
10.5.2 South and Central America Brain Aneurysm Treatment Market Forecasts and Analysis
10.5.3 South and Central America Brain Aneurysm Treatment Market Forecasts and Analysis - By Type
10.5.4 South and Central America Brain Aneurysm Treatment Market Forecasts and Analysis - By Condition
10.5.5 South and Central America Brain Aneurysm Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America Brain Aneurysm Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Brain Aneurysm Treatment Market
10.5.6.1.1 Brazil Brain Aneurysm Treatment Market by Type
10.5.6.1.2 Brazil Brain Aneurysm Treatment Market by Condition
10.5.6.1.3 Brazil Brain Aneurysm Treatment Market by End User
10.5.6.2 Argentina Brain Aneurysm Treatment Market
10.5.6.2.1 Argentina Brain Aneurysm Treatment Market by Type
10.5.6.2.2 Argentina Brain Aneurysm Treatment Market by Condition
10.5.6.2.3 Argentina Brain Aneurysm Treatment Market by End User
10.5.6.3 Rest of South and Central America Brain Aneurysm Treatment Market
10.5.6.3.1 Rest of South and Central America Brain Aneurysm Treatment Market by Type
10.5.6.3.2 Rest of South and Central America Brain Aneurysm Treatment Market by Condition
10.5.6.3.3 Rest of South and Central America Brain Aneurysm Treatment Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BRAIN ANEURYSM TREATMENT MARKET, KEY COMPANY PROFILES
12.1. MEDTRONIC PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOSTON NEUROSCIENCES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. RAUMEDIC AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INTEGRA LIFE SCIENCES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SOPHYSA LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MICROPORT SCIENTIFIC CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ORSAN MEDICAL TECHNOLOGIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SPIEGELBERG GMBH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. JOHNSON & JOHNSON SERVICES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INFRASCAN INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Medtronic plc.
2. Boston neurosciences
3. Raumedic AG
4. Integra life sciences
5. Sophysa ltd.
6. Microport scientific corporation
7. Orsan medical technologies
8. Spiegelberg gmbh
9. Johnson & Johnson services
10. Infrascan Inc.
.